Multi-Parametric MRI for Renal Transplantation
Launched by UNIVERSITY OF MINNESOTA · Jun 16, 2017
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different types of MRI (Magnetic Resonance Imaging) can help assess kidney function in patients who have received a kidney transplant. The researchers want to see if MRI can show how well the transplanted kidney is working and if it can help identify why kidney function might decline. They will also look at how MRI can measure changes in kidney function before and after treatment when problems arise.
To participate in this trial, you need to be a kidney transplant recipient who can speak English and give consent. You may be eligible if you have had a sudden drop in kidney function or if your kidney function has stabilized after treatment. Participants will undergo MRI exams using either a 3T or a more powerful 7T MRI scanner, and some may have multiple sessions. It's important to note that certain medical conditions or devices, such as certain types of implants, pacemakers, or severe claustrophobia, may prevent you from participating. This study is not yet recruiting participants, but it aims to improve how we monitor and treat kidney function after transplantation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Renal Transplant Recipients
- • Capable to consent
- • English speaking
- • For studies with patients with fast worsening renal function: An abrupt (within 48 h) reduction in kidney function currently defined as a percentage increase in serum creatinine of ≥50% (1.5-fold from baseline), or a reduction in urine output (documented oliguria of less than 0.5 mL/kg/h for more than 6 h).
- • For patients with recovered renal allograft function after therapy: renal allograft function as measured by glomerular filtration rate (eGRF) has been recovered and stabilized above a clinical acceptable level, such as 15 ml/min/1.73 mm2.
- Exclusion Criteria:
- • On dialysis due to renal allograft failure
- • Acute and chronic pulmonary disease
- • Pregnancy as reported in CMRR Safety Screen
- • Ferromagnetic implants
- • Any foreign metal objects in the body
- • History of shrapnel or shot gun injury
- • Cardiac pacemakers
- • Defibrillator
- • Neuronal stimulator
- • Magnetic aneurysm clip
- • Large tattoos on the abdomen or the brain and neck, as determined by CMRR Safety Officer
- • Hip replacement
- • Too large to fit in the magnet (BMI \>= 40, approx.)
- • Severe claustrophobia
About University Of Minnesota
The University of Minnesota is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive resources and expertise to conduct cutting-edge studies aimed at improving patient outcomes and addressing critical health challenges. Its robust clinical trial program emphasizes ethical standards, patient safety, and scientific rigor, contributing to the development of novel therapies and interventions that enhance medical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minneapolis, Minnesota, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials